Assura (LON:AGR) Receives Buy Rating from Berenberg Bank

Berenberg Bank reissued their buy rating on shares of Assura (LON:AGRFree Report) in a research note released on Tuesday, Digital Look reports. They currently have a GBX 51 ($0.67) target price on the real estate investment trust’s stock.

Separately, Shore Capital restated a hold rating on shares of Assura in a research report on Tuesday, August 13th.

Check Out Our Latest Stock Report on Assura

Assura Stock Performance

Shares of AGR stock opened at GBX 42.06 ($0.56) on Tuesday. The stock has a market capitalization of £1.36 billion, a PE ratio of -4,206.00, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. Assura has a 52-week low of GBX 37.54 ($0.50) and a 52-week high of GBX 49.18 ($0.65). The stock’s 50-day moving average price is GBX 41.60 and its 200 day moving average price is GBX 41.39. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.04.

Assura Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Wednesday, October 9th. Shareholders of record on Thursday, September 5th will be issued a GBX 0.84 ($0.01) dividend. This represents a yield of 2.01%. The ex-dividend date is Thursday, September 5th. Assura’s dividend payout ratio is presently -30,000.00%.

Insider Buying and Selling at Assura

In other Assura news, insider Jonathan Murphy sold 223,534 shares of Assura stock in a transaction that occurred on Wednesday, July 10th. The stock was sold at an average price of GBX 42 ($0.55), for a total value of £93,884.28 ($124,021.51). 8.38% of the stock is owned by corporate insiders.

About Assura

(Get Free Report)

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

Further Reading

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.